These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7783073)

  • 1. Autoantibodies to the nucleolar organizer antigen NOR-90 in children with systemic rheumatic diseases.
    Fritzler MJ; von Muhlen CA; Toffoli SM; Staub HL; Laxer RM
    J Rheumatol; 1995 Mar; 22(3):521-4. PubMed ID: 7783073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90/hUBF autoantigens.
    Imai H; Fritzler MJ; Neri R; Bombardieri S; Tan EM; Chan EK
    Mol Biol Rep; 1994 Mar; 19(2):115-24. PubMed ID: 8072492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to NOR 90/hUBF: longterm clinical and serological followup in a patient with limited systemic sclerosis suggests an antigen driven immune response.
    Dagher JH; Scheer U; Voit R; Grummt I; Lonzetti L; Raymond Y; Senécal JL
    J Rheumatol; 2002 Jul; 29(7):1543-7. PubMed ID: 12136917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of autoantibodies to nucleolar transcription factor NOR 90/hUBF in sera of patients with rheumatic diseases, by recombinant autoantigen-based assays.
    Fujii T; Mimori T; Akizuki M
    Arthritis Rheum; 1996 Aug; 39(8):1313-8. PubMed ID: 8702439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance and HLA association of autoantibodies against the nucleolus organizer region (NOR-90).
    Dick T; Mierau R; Sternfeld R; Weiner EM; Genth E
    J Rheumatol; 1995 Jan; 22(1):67-72. PubMed ID: 7699685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D; Grodzicky T; Senécal JL
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
    Muro Y; Sugiura K; Morita Y; Tomita Y
    Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to the nucleolar organizer antigen NOR-90 in children with systemic rheumatic diseases.
    Bitter T
    J Rheumatol; 1995 Dec; 22(12):2371. PubMed ID: 8965273
    [No Abstract]   [Full Text] [Related]  

  • 9. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heterogeneity of anticentromere antibodies in immunoblotting analysis.
    Muro Y; Sugimoto K; Okazaki T; Ohashi M
    J Rheumatol; 1990 Aug; 17(8):1042-7. PubMed ID: 2213779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations.
    Greidinger EL; Casciola-Rosen L; Morris SM; Hoffman RW; Rosen A
    Arthritis Rheum; 2000 Apr; 43(4):881-8. PubMed ID: 10765934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
    Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
    J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F.
    Rattner JB; Rees J; Whitehead CM; Casiano CA; Tan EM; Humbel RL; Conrad K; Fritzler MJ
    Clin Invest Med; 1997 Oct; 20(5):308-19. PubMed ID: 9336656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases.
    Decker P; Briand JP; de Murcia G; Pero RW; Isenberg DA; Muller S
    Arthritis Rheum; 1998 May; 41(5):918-26. PubMed ID: 9588745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of autoantibodies against Ki-67 antigen in Japanese patients with systemic autoimmune diseases.
    Muro Y; Kano T; Sugiura K; Hagiwara M
    J Autoimmun; 1997 Oct; 10(5):499-503. PubMed ID: 9376078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.